Application of angelica keiskei aqueous extract in preparation of anti-aging product
By optimizing the water extraction process of Asahi leaves, its anti-aging activity is improved, and the problems of complex extraction methods and low activity are solved, and the significant application of Asahi leaves water extract in the field of anti-aging is achieved.
Patent Information
- Application Number
- CN202311378249.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-24
- Filing Date
- 2023-10-23
- Publication Date
- 2024-11-26
AI Technical Summary
The extraction method of Asahi leaves is complex and the extract activity in the prior art is low, limiting its application in anti-aging products.
Using a water extraction process, including reflux extraction, concentration, drying and crushing, optimized extraction conditions to increase the total flavonoid content and paste yield, prepare efficient Aoi leaf water extract, and combine it with grape seed extract and tomato red micro- The capsule combination forms anti-aging products.
It significantly improves the anti-aging activity of Aokiba water extract, improves muscle strength, motor coordination, cerebral blood flow, cardiac function and memory, and has good application prospects.
Smart Images

Figure CN119015332A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medicine and food, and in particular to an application of an ashitaba leaf water extract in the preparation of an anti-aging product. Background Art
[0002] Ashitaba is native to Hachijo Island, the hometown of longevity in Japan, and is now mainly distributed in the Izu Islands. Chemical composition of Ashitaba: Up to now, 56 flavonoid compounds have been extracted, separated and identified from Ashitaba, and 42 chalcone components represented by flavonol and 4-hydroxydersin have been found. In addition, it also contains flavonoid compounds such as apigenin, coumarin compounds such as apigenin, and sesquiterpenoid compounds have also been discovered in recent years. Ashitaba is a natural plant that can be used as both medicine and food. It contains 20 minerals, 16 amino acids, multiple vitamins, and rich chlorophyll and trace elements. In particular, it contains chalcone, vitamin B12, folic acid and natural organic germanium, which are rare in plants.
[0003] The stems and leaves of tomorrow leaf have been listed as new food raw materials, and are widely used in tea, noodles, desserts and other foods and health products. Its extracts have been approved as cosmetic raw materials in many cases. Although tomorrow leaf has great academic and industrial development value, its role is still not fully utilized. On the one hand, the extraction method of tomorrow leaf is relatively complicated, and on the other hand, the activity of tomorrow leaf extract in the existing technology is relatively low, which limits the application of tomorrow leaf to a certain extent. Summary of the invention
[0004] In order to solve one of the above technical problems existing in the prior art, the present invention provides an application of an aqueous extract of Angelica keiskei in the preparation of an anti-aging product. The aqueous extract of Angelica keiskei can resist aging, has good application prospects in improving muscle strength, improving motor coordination, improving cerebral blood flow, improving cardiac function or improving memory, and improving social cognitive ability, and exhibits significant anti-aging activity.
[0005] In a first aspect, the present invention provides a use of an aqueous extract of Angelica keiskei in the preparation of an anti-aging product.
[0006] In some embodiments, the anti-aging is to improve the functions of the central nervous system, motor system and / or cardiovascular and cerebrovascular system.
[0007] In some embodiments, the anti-aging is one or more of improving muscle strength, improving motor coordination, improving hair loss, improving energy metabolism, improving cerebral blood flow, improving cardiac function or improving memory, and improving social cognitive ability.
[0008] According to an embodiment of the present invention, the preparation method of the Angelica keiskei water extract comprises the following steps: step S1, reflux extraction of the Angelica keiskei with water to obtain an extract; step S2, concentrating the extract to obtain an extract; step S3, drying the extract to obtain a dry extract.
[0009] According to an embodiment of the present invention, the Angelica keiskei is selected from the stems of Angelica keiskei and leaves of Angelica keiskei.
[0010] According to an embodiment of the present invention, the preparation method of the Angelica keiskei water extract further comprises crushing the dry paste to obtain Angelica keiskei water extract dry paste powder.
[0011] According to an embodiment of the present invention, the mesh number of the sieve used to grind the dry paste is 60-80 meshes, preferably 80 meshes.
[0012] According to an embodiment of the present invention, in step S1, the mass of the water is 10-15 times, preferably 12 times, the mass of the Angelica keiskei leaves; preferably, the number of reflux extractions is at least 1 time, preferably 2-3 times; preferably, the time for each reflux extraction is 1-2 hours, preferably 1.5 hours.
[0013] According to an embodiment of the present invention, in step S2, the concentration method includes vacuum concentration. Preferably, the temperature of the vacuum concentration is 40-90°C.
[0014] According to an embodiment of the present invention, in the step S2, the vacuum degree of the vacuum decompression concentration is 0.04-0.1 MPa, preferably 0.04-0.08 MPa.
[0015] According to an embodiment of the present invention, the relative density of the extract at 60°C is 1.25-1.30. After the relative density of the extract reaches 1.30 (60°C), the extract begins to cling to the wall, the fluidity becomes poor, and the concentration efficiency is low. If the concentration is continued, it is found that the extract clings to the wall severely, and even the extract cannot be smoothly produced. To avoid waste, the extract is preferably produced at a relative density of 1.25-1.30 (60°C).
[0016] The drying method of the present invention can be vacuum oven drying, spray drying and vacuum belt drying. However, the dry paste powder obtained by spray drying is fluffy, has a high moisture content and is easy to agglomerate; the vacuum oven drying efficiency is low; the vacuum belt drying efficiency is high and the dry paste powder has low moisture content. According to an embodiment of the present invention, in step S3, the drying method is vacuum drying, preferably vacuum belt drying.
[0017] According to an embodiment of the present invention, in step S3, the drying temperature is 105-120°C.
[0018] According to an embodiment of the present invention, in step S3, the vacuum degree of drying is 0.04-0.1 MPa, preferably 0.04-0.08 MPa.
[0019] According to an embodiment of the present invention, the Angelica keiskei water extract contains 7.5-17.5 mg / g of total flavonoids.
[0020] According to an embodiment of the present invention, the extract yield of the Angelica keiskei water extract is above 20%, preferably 25%-40%.
[0021] According to an embodiment of the present invention, the product is food or medicine.
[0022] According to an embodiment of the present invention, the food is selected from common food or health food.
[0023] According to an embodiment of the present invention, the product is a composition containing Angelica keiskei water extract, grape seed extract and lycopene microcapsules.
[0024] According to an embodiment of the present invention, the dosage form of the product is selected from capsules, powders, granules, tablets or suspensions.
[0025] According to an embodiment of the present invention, the preparation method of the composition containing Angelica keiskei water extract, grape seed extract, and lycopene microcapsules includes: a. placing the formulated amount of Angelica keiskei water extract dry paste powder, grape seed extract and corn starch in a mixer, adjusting the speed to 6-15rpm, for example, 8rpm, mixing for example, 20min, to obtain a mixed powder; b. dry granulating the mixed powder obtained in step a, setting the main pressure to 6-10MPa, passing through a 14-mesh sieve, collecting the particles for standby use; c. placing the particles obtained in step b, lycopene microcapsules, and magnesium stearate in a mixer, rotating at a speed of 6-15rpm, for example, 8rpm, mixing for example, 30min, to obtain total mixed particles, for standby use; d. filling capsules with the total mixed particles prepared in step c.
[0026] The Angelica keiskei extract provided by the present invention has good application prospects in the fields of anti-aging, improving muscle strength and endurance, improving motor coordination, improving hair loss, improving energy metabolism, improving cerebral blood flow, improving cardiac function or improving memory, improving social cognitive ability, etc., and shows significant anti-aging activity. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 This is the normal life span curve of nematodes.
[0028] Figure 2 This is the survival curve of nematodes under the heat shock model.
[0029] Figure 3 This is the survival curve of nematodes under the H2O2 model.
[0030] Figure 4 It is a bar graph of serum oxidation indexes (GSH, SOD, MDA).
[0031] Figure 5 It is a bar graph of gastrocnemius muscle indices (gastrocnemius muscle coefficient, gastrocnemius muscle cross-sectional area).
[0032] Figure 6 It is a bar graph of cardiac indicators (valvular pigmentation, heart area, heart diameter).
[0033] Figure 7 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - Barnes maze short-term memory - latency bar graph.
[0034] Figure 8 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - Barnes maze short-term memory - total time bar graph.
[0035] Fig. 9 Effects of Angelica keiskei water extract and alcohol extract on natural aging of mice - Barnes maze short-term memory - total distance bar graph.
[0036] Fig.10 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - Barnes maze long-term memory - latency bar graph.
[0037] Fig.11 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - Barnes maze long-term memory - total time bar graph.
[0038] Fig.12 Effects of Angelica keiskei water extract and alcohol extract on natural aging of mice - Barnes maze long-term memory - total distance bar graph.
[0039] Fig.13 The effects of water extract and alcohol extract of Angelica keiskei on natural aging in mice - social preference bar graph.
[0040] Fig.14 The effects of water extract and alcohol extract of Angelica keiskei on natural aging in mice - social novelty bar graph.
[0041] Fig.15 This is the effect of Angelica keiskei water extract and alcohol extract on natural aging in mice - muscle strength bar graph.
[0042] Fig.16 The effects of water extract and alcohol extract of Angelica keiskei on natural aging in mice - rotating bar graph.
[0043] Fig.17This is the effect of Angelica keiskei water extract and alcohol extract on natural aging in mice - cardiac function bar graph.
[0044] Fig.18 This is the effect of Angelica keiskei water extract and alcohol extract on natural aging in mice - cerebral blood flow - velocity bar graph.
[0045] Fig.19 This is the effect of Angelica keiskei water extract and alcohol extract on natural aging in mice - cerebral blood flow - VTI bar graph. DETAILED DESCRIPTION
[0046] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments and drawings. The specific embodiments described herein are only used to explain the present invention and are not intended to constitute any limitation to the present invention.
[0047] Part I: Preparation of Angelica keiskei aqueous extract
[0048] Water extraction process optimization test
[0049] Three factors, namely the number of extractions, extraction time and amount of water added, which have a greater impact on the extraction, were selected to investigate the total flavonoids content and the yield of the paste. The factor levels of the orthogonal experiment of the water extraction process are shown in Table 1, and the experimental factor variables and results are shown in Table 2.
[0050] Table 1
[0051]
[0052] Table 2
[0053]
[0054]
[0055] The test methods include:
[0056] Weigh 20 g of Angelica keiskei, weigh 9 portions, and perform reflux extraction according to the orthogonal table in Table 2. Filter the extract and transfer the filtrate to a 500 mL volumetric flask (the third extract of Test 7 and Test 9 is appropriately concentrated and then transferred to a 500 ml volumetric flask), cool, dilute to the mark with water, shake well, and set aside.
[0057] Determination of total flavonoids content
[0058] Determination method: refer to the "Determination of total flavonoids in health foods" method in the "Technical Specifications for Inspection and Evaluation of Health Foods" (2003 edition), without using benzene to remove impurities, and directly elute the flavonoids for determination.
[0059] Preparation of rutin standard solution: Accurately weigh 54.51 mg of rutin reference substance (purity 92.6%), dissolve in methanol and make up to 50 mL. Accurately measure 5 mL and place in a 100 mL volumetric flask, add methanol to dilute to the mark, shake well, and obtain 50.4750 μg / mL rutin standard solution.
[0060] Rutin standard curve: Pipette rutin standard solution: 0, 1.0, 2.0, 3.0, 4.0, 5.0 mL into a 10 mL volumetric flask, add methanol to the mark, shake well, and compare colors at a wavelength of 360 nm. Find the regression equation.
[0061] Preparation of test solution: Accurately take 1 mL of each extract, put it in an evaporating dish, add 1 g of polyamide powder (100-200 mesh) for adsorption, evaporate it on a water bath, then transfer it to a chromatography column, elute the flavonoids with methanol, and make up to 25 mL. The absorbance of this solution is measured at a wavelength of 360 nm, and the total flavonoid content in the sample is calculated according to the regression equation.
[0062] Determination of paste yield
[0063] Take 100 mL of the shaken extract and pour it into a dried evaporating dish. Concentrate it in a water bath until it is nearly dry. Dry it under reduced pressure at 60°C. Measure the weight of the dry paste and calculate the paste rate.
[0064] As shown in Table 2, taking total flavonoids as the evaluation index, the influence of each factor on the content is in the order of number of extractions > extraction time > amount of water added, and the best process is A3B2C3; taking the paste yield as the evaluation index, the influence of each factor is in the order of number of extractions > amount of water added > extraction time, and the best process is A3B3C3.
[0065] ANOVA
[0066] The experimental data were subjected to variance analysis and the significance of the effect of each factor was tested. The results are shown in Tables 3 and 4 below.
[0067] Table 3
[0068] factor Sum of Squared Deviations Degrees of Freedom F Ratio F critical value Significance Extraction times A 19349.843 2 37.572 19.000 * Extraction time B 841.012 2 1.633 19.000 Water addition amount C 642.739 2 1.248 19.000 error 515.000 2
[0069] F0.05(2,2)=19.000
[0070] Table 4
[0071] factor Sum of Squared Deviations Degrees of Freedom F Ratio F critical value Significance Extraction times A 187.054 2 298.332 19.000 * Extraction time B 5.313 2 8.474 19.000 Water addition amount C 5.915 2 9.434 19.000 error 0.630 2
[0072] F0.05(2,2)=19.000
[0073] The results of variance analysis showed that the difference in extraction times (A) had statistical significance for both total flavonoids (P<0.05) and paste yield (P<0.05), while the differences in other factors were not statistically significant.
[0074] Taking total flavonoids as the evaluation index, the best process is A3B2C3; taking the paste yield as the evaluation index, the best process is A3B3C3. Comparing the results of extraction time 1.5h and 2.0h, the paste yield is basically the same; therefore, the best process is determined to be A3B2C3 after comprehensive consideration, that is, adding 12 times of water, extracting 3 times, each time for 1.5h. ② The variance analysis showed that only the number of extractions had a significant difference. Considering that the total flavonoid content and the paste yield increased less when extracting 3 times than when extracting 2 times, in line with the principle of cost saving, extraction 2 times was selected; there was no significant difference in other factors, and any level could be selected. After optimization, the extraction process determined was A2B2C3, that is, adding 12 times of water, extracting 2 times, each time for 1.5h.
[0075] Verification test
[0076] Weigh 20g of Angelica keiskei, weigh 6 portions, extract by reflux according to the best process A3B2C3 and the best process A2B2C3, filter the extract, transfer the filtrate to a 500mL volumetric flask (the third extract of the best process is appropriately concentrated and then transferred to a 500mL volumetric flask), cool, dilute to the mark with water, shake well, and set aside. Detect the total flavonoid content and the paste yield.
[0077] The measurement results are shown in Table 5 below.
[0078] Table 5
[0079]
[0080] From the test results, it can be seen that the total flavonoids content and the paste yield of the optimal process and the preferred process are not much different. Considering labor and energy saving, the preferred process is selected for extraction, that is, adding 12 times the amount of water to extract twice, each time for 1.5 hours.
[0081] Example 1
[0082] The preparation method of the Angelica keiskei water extract is as follows:
[0083] (1) Weighing and adding materials: Weigh 10 kg of Angelica keiskei leaves and set aside.
[0084] (2) Extraction: Add 12 times the amount of water, reflux extraction twice, each extraction time for 1.5 hours, filter the extract, combine the filtrate and set aside.
[0085] (3) Concentration: The extract is concentrated under reduced pressure (concentration temperature 60°C, vacuum degree 0.6 MPa) to a relative density of 1.26 (60°C) to obtain an extract for later use.
[0086] (4) Drying: The extract was dried by vacuum belt drying (heating plate temperature 115°C, vacuum degree 0.08 MPa), and the dry paste was collected. The moisture content of the dry paste should be controlled within 5%. A total of 3.09 kg of dry paste was obtained, with an extract yield of 30.9%. The amount of raw drug in the dry paste was 3.23 g raw drug / g dry paste, which was set aside.
[0087] (5) Grinding: Grind the dry paste (mesh size: 80 mesh), collect the dry paste powder, and obtain 3.01 kg of dry paste powder with a grinding yield of 97.4%, which is set aside.
[0088] Part II Preparation of Angelica keiskei ethanol extract
[0089] Example 2
[0090] The preparation method of the ethanol extract of Angelica keiskei is as follows:
[0091] (1) Weighing and adding materials: Weigh 10 kg of Angelica keiskei according to the formula ratio and set aside.
[0092] (2) Extraction: Add 10 times the amount of 60% ethanol, reflux extraction twice, each extraction time for 1.5 hours, filter the extract and keep the filtrate for later use.
[0093] (3) Concentration: The extract is decompressed to recover ethanol and concentrated (concentration temperature 60°C, vacuum degree 0.7 MPa) to a relative density of 1.25 (60°C) to obtain an extract for later use.
[0094] (4) Drying: The extract was dried in a vacuum oven (temperature 70°C, vacuum degree 0.08 MPa), and the dry paste was collected. The moisture content of the dry paste should be controlled within 5%. A total of 2.75 kg of dry paste was obtained, with an extract yield of 27.5%. The amount of raw drug in the dry paste was 3.63 g of raw drug / g of dry paste, and it was set aside.
[0095] (5) Grinding: Grind the dry paste (sieve mesh number: 80 mesh), collect the dry paste powder, and obtain 2.68 kg of dry paste powder with a grinding yield of 97.5%, which is set aside.
[0096] Part III Application Test
[0097] The Angelica keiskei water extract prepared in Example 1 and the Angelica keiskei alcohol extract prepared in Example 2 were subjected to the following application tests.
[0098] 1. Nematode Test
[0099] The Angelica keiskei water extract prepared in Example 1 was used to prepare aqueous solutions with concentrations of 5 mg / mL, 500 μg / mL, and 50 μg / mL, respectively, and rapamycin 25 uM was used for nematode test, and a solvent control was performed.
[0100] The survival period of normal nematodes is shown in Table 6 and Figure 1 As shown in Table 7 and Figure 2 The survival period of nematodes under the H2O2 oxidative stress model is shown in Table 8 and Figure 3 shown.
[0101] Table 6
[0102]
[0103]
[0104] Note: Compared with the vehicle control group, *P<0.05, **P<0.01.
[0105] Table 7
[0106] Average value(h) Median(h) Solvent control 5.192 6 Angelica keiskei water extract 5mg / mL 7.038*** 8 Angelica keiskei water extract 500μg / mL 6.254** 6 Angelica keiskei water extract 50μg / mL 5.679 6 Angelica keiskei water extract 5μg / mL 5.143 6 Angelica keiskei water extract 500ng / mL 5.059 6 Rapamycin 25uM 6.131** 8
[0107] Table 8
[0108] Average value(h) Median(h) Solvent control 6.077 1 Angelica keiskei water extract 5mg / mL 9.806* 3 Angelica keiskei water extract 500μg / mL 8.103 1 Angelica keiskei water extract 50μg / mL 6.838 1 Rapamycin 25uM 11.5** 19
[0109] According to Tables 6, 7 and 8 and Figure 1 , 2 As shown in Figure 3, the concentration of Angelica keiskei water extract is 5 mg / mL and 500 μg / mL, which can significantly prolong the survival period of nematodes under normal and heat shock models. The concentration of Angelica keiskei water extract is 5 mg / mL, which can significantly prolong the survival period of nematodes under hydrogen peroxide model. Therefore, Angelica keiskei water extract has the effect of prolonging the lifespan of nematodes and resisting oxidative stress.
[0110] 2. Antioxidant performance test
[0111] 2.1 Experimental animals: C57BL / 6J mice, male, 11-12 months old, 32-35 g.
[0112] 2.2 Experimental groups: solvent control group, STW low-dose group, STW medium-dose group, STW high-dose group, where the solvent was pure water.
[0113] 2.3 Drug dosage: STW low-dose group (0.333 g crude drug / kg), STW medium-dose group (0.667 g crude drug / kg), STW high-dose group (1.333 g crude drug / kg).
[0114] 2.4 Administration: Administration by gavage, once a day, for 30 consecutive days.
[0115] 2.5 Evaluation indicators: Antioxidant biochemical indexes in serum (superoxide dismutase, malondialdehyde, reduced glutathione, protein carbonyl), gastrocnemius muscle index (gastrocnemius muscle coefficient, gastrocnemius muscle fiber cross-sectional area), heart index (heart coefficient, heart area, maximum heart diameter, heart valve lipofuscin deposition).
[0116] 2.5.1 Serum oxidation index test
[0117] From Table 9 and Figure 4 It can be seen that compared with the solvent control group: low, medium and high doses of STW can increase the GSH content in the serum of naturally aged mice, increase the SOD activity and SOD inhibition rate in the serum, and reduce the protein carbonyl and MDA content in the serum, showing a certain antioxidant effect.
[0118] Table 9
[0119]
[0120] Note: Compared with the solvent control group, *P<0.05, **P<0.01
[0121] 2.5.2 Gastrocnemius muscle index test
[0122] From Tables 10, 11 and Figure 5 It can be seen that compared with the solvent control group: high-dose STW can significantly increase the gastrocnemius muscle coefficient and tend to increase the cross-sectional area of muscle fibers.
[0123] Table 10
[0124] Group Gastrocnemius muscle coefficient (g / kg) Solvent control group 4.33±0.65 STW low dose group 4.62±0.93 STW high dose group 4.91±0.49*
[0125] Note: Compared with the solvent control group, *P<0.05, **P<0.01
[0126] Table 11
[0127] Group <![CDATA[Cross-sectional area of muscle fiber (μm 2 )]]> Solvent control group 1502.84±707.37 STW high dose group 1779.17±673.54
[0128] Note: Compared with the solvent control group, *P<0.05, **P<0.01
[0129] 2.5.3 Cardiac indicators
[0130] From Table 12 and Figure 6 It can be seen that compared with the solvent control group: high-dose STW can reduce the maximum diameter of the heart, reduce lipofuscin deposition in the heart valves, and tend to reduce the heart area.
[0131] Table 12
[0132] Group Valve pigment deposition ratio <![CDATA[Heart area (mm 2 )]]> Maximum heart diameter (mm) Solvent control group 35.71 29.83±2.93 5.90±0.46 STW high dose group 18.18 26.90±1.24 5.14±0.33*
[0133] Note: Compared with the solvent control group, *P<0.05, **P<0.01
[0134] 3. Anti-aging test
[0135] Aging refers to the overall phenomenon of the gradual decline of the structure, function, metabolism, and adaptability of the body. With the development of the times, the trend of population aging has become increasingly obvious. Delaying aging to reduce the incidence of chronic diseases is of great significance in an increasingly aging society. In this experiment, naturally aged mice were selected to simulate the natural aging process of humans, and the anti-aging effect of the test article was studied.
[0136] 3.1 Test article
[0137] Name: Aqueous extract of Angelica keiskei Koidzumi (Example 1), ethanol extract of Angelica keiskei Koidzumi (Example 2).
[0138] 3.2 Tool drugs, main reagents and materials
[0139] Isoflurane: Beijing Youcheng Jiaye Biotechnology Co., Ltd., batch number: G45780, expiration date: December 2024.
[0140] 3.3 Test animals: C57BL / 6j mice.
[0141] Animal level: SPF level.
[0142] Animal gender and quantity: 110, female.
[0143] Animal age at the start of dosing: Approximately 16 - 17 months old actually. About 21 - 22 months old at the end of dosing.
[0144] Animal weight at the start of dosing: 25 - 35 g.
[0145] Animal source: Purchased from Beijing Huafukang Biotechnology Co., Ltd.
[0146] Feeding conditions: Mice were caged and raised in the New Drug Evaluation Center of Hebei Yiling Pharmaceutical Research Institute Co., Ltd. The light was 12 hours per day, the temperature was 20 - 26 °C, and the relative humidity was 40 - 70%. The license number for the use of experimental animals: SYXK (Ji) 2020 - 003.
[0147] General observation: Since the animals were still in the original animal house, general observations were carried out. During this period, the drinking water, food intake, and health status of the animals were observed, as well as the signs of disease and death.
[0148] Feed: SPF mouse and rat maintenance feed, provided by Beijing Huafukang Biotechnology Co., Ltd., feed batch numbers: 2210250511, 2210250628, 2210250810, 2210251017, license number: SCXK (Jing) 2019 - 0008. Medicated feed, provided by Jiangsu Xietong Pharmaceutical Biotechnology Co., Ltd., feed batch numbers: 20220707, 20220815, 20221116, license number: Su Sizheng (2019) 01008.
[0149] Drinking water: The animals were provided with clean water prepared by the ROA50 experimental animal drinking water system (instrument number YL-LE-A01), which was filled in drinking water bottles for free drinking. The water quality was tested and met the "Sanitary Standards for Drinking Water".
[0150] Bedding: Ordinary grade corn cob bedding, the bedding is sterilized at high temperature and high pressure before use, provided by Beijing Keao Xieli Feed Co., Ltd., bedding batch number: 22049811, 22089811, license number: SCXK(Beijing)2020-0010.
[0151] Identification: Ear tag for experimental animals.
[0152] Notify the animal room when purchasing animals, and notify the pathology room for treatment when animals show abnormal conditions.
[0153] 3.4 Dosage and Grouping
[0154] According to relevant literature and previous experimental studies, the low dose and high dose of Angelica keiskei water extract and Angelica keiskei alcohol extract were 11g crude drug / kg and 22g crude drug / kg, respectively. 110 C57BL / 6j mice were divided into 5 groups according to the Barnes maze data, including model control group, STW low dose group, STW high dose group, CTW low dose group, and CTW high dose group, as shown in Table 13.
[0155] Table 13 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - grouping and dosage setting
[0156]
[0157] 3.5 Administration and cycle: Add to customized feed, consistent with the intended route of use.
[0158] 3.6 Preparation and storage of test samples
[0159] According to the corresponding dosage setting, calculate the feed preparation concentration, combine the number of animals and the animal feed intake to calculate the required amount of medicine, mix it evenly in the feed, and store the feed at room temperature for use.
[0160] 3.7 Administration of test article
[0161] The test article was orally administered via feed, the animals in the model control group were given SPF mouse and rat maintenance feed, and the animals in the treatment group were given corresponding customized feed for 14 consecutive weeks.
[0162] 3.8 Instrument system
[0163] Mettler ME104E analytical balance (YL-LE-B007), METTLER TOLEDO.
[0164] DT2000 electronic balance (YL-LE-B045), Changshu Shuangjie Testing Instrument Factory.
[0165] Barnes maze (YL-LE-A62), Shanghai Jiliang Software Technology Co., Ltd.
[0166] Animal motion trajectory tracking system (YL-LE-A124), Nordus (Beijing) Information Technology Co., Ltd.
[0167] IITC Rotarod Fatigue Apparatus for Rats and Mice (YL-LE-A051), IITC Biological Sciences.
[0168] VEVO 3100LT Small Animal Ultrasound System (YL-LE-A085), FUJIFILM VisualSonics, Inc.
[0169] 3.9 Statistical methods
[0170] The experimental data were analyzed and processed using SPSS20.0 statistical software, with a test level of 0.05 and 0.01. The results were expressed as mean ± standard deviation (x ± s). Normality test was first performed. For data that conformed to normal distribution, one-way ANOVA was used for mean comparison. If the variances were equal, the least significant difference method (LSD) was used for pairwise comparisons. If the variances were unequal, Dunnett's T3 test was used for pairwise comparisons. If it did not conform to normal distribution, nonparametric tests were used. Chi-square test or rank sum test was used for count data.
[0171] 3.10 Evaluation indicators
[0172] 3.10.1 Spatial learning and memory ability (Barnes maze)
[0173] Test method: The mice were measured before and 12 weeks after administration.
[0174] Before the test, a blue background cloth was laid flat on the operating table to ensure that the background color was distinguishable from the color of the mouse. At the beginning of the adaptive training, the mouse was placed in the center of the maze to adapt for 10 seconds, and then the mouse was guided into the target box, where it stayed for 10 seconds, and then guided into the box again, for a total of 3 times. During the test, the detection software was turned on for video acquisition, and the mouse was restricted from moving in a light-proof box for 6 seconds. The light-proof box was removed and the timing started at the same time. When all four limbs of the mouse entered the target box (the target box was equipped with dark areas and steps to make it easy for the mouse to avoid), it was counted as one successful avoidance, and the mouse stayed in the target box for 3 seconds. Each mouse was observed for 3 minutes each time. Between the tests of two mice, the maze area and the target box were wiped with 75% alcohol (to prevent the mouse from relying on smell rather than memory to determine the location of the target box). The mice were trained once a day for 3 consecutive days. The learning and memory ability was formally tested on the 4th day, and the long-term memory ability was tested on the 11th day. The software was used to collect parameters such as latency, total distance, and total time for statistical analysis, as shown in Tables 14, 15, 16 and Figure 7 , 8 , 9, 10, 11, and 12.
[0175] (1) Short-term memory
[0176] Before administration: Compared with the model control group, there was no statistical difference in the incubation period, total time and total distance among the groups.
[0177] Dosing for 12 weeks:
[0178] Incubation period: Compared with the model control group, the incubation period of the high-dose STW group was significantly reduced (P < 0.05).
[0179] Total time: Compared with the model control group, the total time of the STW high-dose group was significantly reduced (P < 0.05).
[0180] Total distance: Compared with the model control group, there was no statistical difference among the groups.
[0181] (2) Long-term memory
[0182] Dosing for 12 weeks:
[0183] Incubation period: Compared with the model control group, the incubation period of the high-dose STW group was significantly reduced (P < 0.05).
[0184] Total time: Compared with the model control group, the total time of the STW high-dose group was significantly reduced (P < 0.05).
[0185] Total distance: Compared with the model control group, the total distance in the STW high-dose group was significantly reduced (P < 0.05).
[0186] Table 14 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - Barnes maze - latency (s)
[0187]
[0188] Note: Compared with the model control group*, *P<0.05, **P<0.01
[0189] Table 15 Effects of Angelica keiskei water extract and alcohol extract on natural aging of mice - Barnes maze - total time (s)
[0190]
[0191] Note: Compared with the model control group, *P<0.05, **P<0.01
[0192] Table 16 Effects of Angelica keiskei water extract and alcohol extract on natural aging of mice - Barnes maze - total distance (mm)
[0193]
[0194] Note: Compared with the model control group, *P<0.05, **P<0.01
[0195] 3.8.2 Social cognition (three-compartment experiment)
[0196] The mice were measured using an animal motion trajectory tracking system 12 weeks after administration.
[0197] The three-chamber experimental apparatus is 100cm×40cm×30cm, consisting of a central chamber and two left and right side chambers. Mice can freely explore the entire apparatus through the openings of the central chamber and the side chambers. There is an empty restraint cage in each of the left and right side chambers.
[0198] Phase 1: Place the mouse in the central chamber to adapt for 1 minute, then place a spare mouse A from the same batch but different cage in the restraint cage in the right chamber, avoiding the mouse's sight, open the baffles on the left and right sides of the central chamber, and let it explore freely for 10 minutes. At the same time, use a video camera and EthoVision XT software to record and analyze its time in the left and right chambers and the frequency of contact with mouse A (i.e., exploration time and exploration frequency). The total time the mouse enters the left and right chambers is used as the denominator, and the time the mouse enters the right chamber is used as the numerator to calculate the social index.
[0199] Phase 2: After the first phase, the mice were driven into the central chamber, and the baffles on the left and right sides were closed. Then, a spare mouse B from the same batch but in a different cage was placed in the restraint cage in the left chamber to avoid the sight of the mice. The baffles on the left and right sides of the central chamber were opened to allow the mice to explore freely for 10 minutes. At the same time, the time spent in the left and right chambers and the frequency of contact with mice A and B were recorded and analyzed by a video camera and EthoVision XT software (the time spent in the left chamber and the frequency of contact with mouse B were exploration time and exploration frequency, respectively). The total time the mice entered the left and right chambers was used as the denominator, and the time the mice entered the left chamber was used as the numerator to calculate the social novelty index.
[0200] Table 17 Effects of Angelica keiskei water extract and alcohol extract on natural aging of mice - three-compartment experiment
[0201]
[0202]
[0203] *Compared with the model control group, *P<0.05, **P<0.01.
[0204] From Table 17 and Fig.13 and Fig.14 It can be seen that
[0205] (1) Social Preference
[0206] Exploration time: Compared with the model control group, the exploration time of the CTW low-dose group was significantly increased (P < 0.05), and the exploration time of the STW low-dose group, STW high-dose group, and CTW high-dose group was significantly increased (P < 0.01).
[0207] Social index: Compared with the model control group, the social index of the CTW low-dose group was significantly increased (P < 0.05), and the social index of the STW low-dose group, STW high-dose group and CTW high-dose group was significantly increased (P < 0.01).
[0208] (2) Social novelty
[0209] Exploration time: Compared with the model control group, the exploration time of the STW low-dose group, STW high-dose group, CTW low-dose group, and CTW high-dose group was significantly increased (P < 0.01).
[0210] Social novelty index: Compared with the model control group, the social novelty index of the STW low-dose group, STW high-dose group, CTW low-dose group, and CTW high-dose group was significantly increased (P < 0.01).
[0211] 3.8.3 Muscle strength
[0212] The mice were measured after 12 weeks of administration.
[0213] Muscle strength (hanging test): Place the mouse on a hanging net (specification: 3 mesh, 40 cm diameter, Shanghai Yanjin Screen Factory). After its limbs grasp the net firmly, invert the hanging net at a height of 1 meter and start timing at the same time to record the time when each mouse lands. Measure twice and take the average value.
[0214] Table 18 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - muscle strength
[0215] Group Hanging time(s) Model control group 251.48±116.40 STW low dose group 309.78±139.52 STW high dose group 341.98±126.36* CTW low dose group 288.38±100.88 CTW high dose group 307.10±99.71
[0216] Compared with the model control group, *P<0.05, **P<0.01.
[0217] According to Table 18 and Fig.15 It can be seen that after 12 weeks of administration, the suspension time of the STW high-dose group was significantly increased compared with the model control group (P < 0.05).
[0218] 3.8.4 Motor coordination ability (rotarod)
[0219] The mice were measured after 12 weeks of administration.
[0220] Set the starting speed of the rotarod to 2 rpm, the maximum speed to 20 rpm, and the acceleration time to 30 s. Place the mouse on the rotarod, start the rotarod, and record its falling latency, speed when falling, and movement distance when falling. The mouse practices once, and the formal test is performed the second time.
[0221] Table 19 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - Rotarod
[0222]
[0223] Compared with the model control group, *P<0.05, **P<0.01
[0224] According to Table 19 and Fig.16 It can be seen that
[0225] Fall latency: After 12 weeks of administration, the fall latency in the STW high-dose group was significantly increased compared with the model control group (P < 0.05).
[0226] Rotational speed when falling: After 12 weeks of administration, the rotational speed when falling in the STW high-dose group was significantly increased compared with the model control group (P < 0.05).
[0227] Movement distance when falling: After 12 weeks of administration, the movement distance when falling in the STW high-dose group was significantly increased compared with the model control group (P < 0.05).
[0228] 3.8.5 Cardiac function
[0229] After 12 weeks of administration, the cardiac function of the mice was detected using a small animal ultrasound system.
[0230] Mice were anesthetized with 2.5% isoflurane and fixed in a supine position on a physiological monitoring platform. Electrocardiogram, respiration and body temperature were monitored, and anesthesia was maintained with 1% isoflurane. Lubricating ointment was applied to the eyes of the mice to prevent dryness of the eyes, chest hair was removed, and ultrasound gel was applied to the chest. A linear array transducer (MX400) with a center frequency of 30 MHz was used to collect long-axis images of the left ventricle of the heart in M mode and B mode, and software was used to analyze indicators such as left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS).
[0231] Table 20 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - cardiac function
[0232] Group LVEF (%) LVFS(%) Model control group 59.55±17.48 31.97±11.06 STW low dose group 68.88±9.39 38.14±7.12 STW high dose group 74.79±11.19* 43.80±9.80** CTW low dose group 68.92±8.00 37.70±5.55 CTW high dose group 70.58±8.13 38.91±6.38
[0233] Compared with the model control group, *P<0.05, **P<0.01.
[0234] From Table 20 and Fig.17 It can be seen that
[0235] Left ventricular ejection fraction (LVEF): Compared with the model control group, the LVEF in the STW high-dose group was significantly increased (P<0.05).
[0236] Left ventricular fractional shortening (LVFS): Compared with the model control group, the LVFS in the STW high-dose group was significantly increased (P < 0.01).
[0237] 3.8.6 Cerebral blood flow
[0238] After 12 weeks of drug administration, the cerebral blood flow of mice was detected using a small animal ultrasound system.
[0239] Mice were anesthetized with 2.5% isoflurane and fixed in a prone position on a physiological monitoring platform. Electrocardiogram, respiration and body temperature were monitored, and anesthesia was maintained with 1% isoflurane. Lubricating ointment was applied to the eyes of the mice to prevent dryness of the eyes, the hair on the head was shaved, and ultrasound gel preheated to 37°C was applied to the head. A linear array transducer (MX400) with a center frequency of 30MHz was used to obtain the blood flow of the middle cerebral artery, posterior communicating artery, and posterior artery of the mice in pulsed Doppler mode. The sample volume (Sample Volume, SVgate) was 0.34, the PRF (Pulse repetition frequency) value was 10 Hz, and the mean value of the three arteries was measured. If repeated acquisition was not possible, the blood flow of the artery was counted as 0. The software was used to analyze cerebral blood flow indicators such as mean blood velocity (mean velocity, MeanVel), time velocity integral (VTI), peak systolic velocity (PSV), and end diastolic blood velocity (EDV).
[0240] Table 21 Effects of Angelica keiskei water extract and alcohol extract on natural aging in mice - cerebral blood flow
[0241]
[0242]
[0243] Compared with the model control group, *P<0.05, **P<0.01.
[0244] From Table 21 and Fig.18 and Fig.19 It can be seen that
[0245] End-systolic blood flow velocity (PSV): Compared with the model control group, the end-systolic cerebral blood flow in the high-dose STW group was significantly increased (P < 0.01).
[0246] End-diastolic blood flow velocity (EDV): Compared with the model control group, the end-diastolic cerebral blood flow velocity in the high-dose STW group was significantly increased (P < 0.05).
[0247] Mean blood velocity (Mean Vel): Compared with the model control group, the mean blood velocity in the STW high-dose group was significantly increased (P < 0.01).
[0248] Time velocity integral (VTI): Compared with the model control group, the time velocity integral of the STW high-dose group was significantly increased (P<0.05).
[0249] In summary, for naturally aged mice, Angelica keiskei water extract can improve learning and memory ability (short-term memory and long-term memory) and social cognition ability (social preference and social novelty), improve muscle strength and motor coordination, improve cardiac function, and improve brain circulation; Angelica keiskei alcohol extract can improve social cognition ability (social preference and social novelty). In summary, Angelica keiskei water extract has improved the central nervous system, motor system, cardiovascular and cerebrovascular system of naturally aged mice, and is superior to Angelica keiskei alcohol extract.
[0250] The technical solution of the present invention is not limited to the above-mentioned specific embodiments. All technical variations made according to the technical solution of the present invention fall within the protection scope of the present invention.
Claims
1. Use of an aqueous extract of Angelica keiskei in the preparation of anti-aging products, Preferably, the anti-aging is to improve the functions of the central nervous system, motor system and / or cardiovascular and cerebrovascular system; Preferably, the anti-aging effect is one or more of improving muscle strength and endurance, improving motor coordination, improving cerebral blood flow, improving cardiac function or improving memory, and improving social cognitive ability.
2. The use according to claim 1, characterized in that: The preparation method of the Angelica keiskei water extract comprises the following steps: Step S1, performing reflux extraction on Angelica keiskei with water to obtain an extract; Step S2, concentrating the extract to obtain an extract; Step S3, drying the extract to obtain a dry extract, Optionally, the dry paste is crushed to obtain Angelica keiskei water-extracted dry paste powder.
3. The use according to claim 2, characterized in that: In the step S1, The Angelica keiskei is selected from the stems of Angelica keiskei and leaves of Angelica keiskei; and / or The mass of the water is 10-15 times, preferably 12 times, the mass of the Angelica keiskei; Preferably, the reflux extraction is performed at least once, preferably 2-3 times; Preferably, the time of each reflux extraction is 1-2 h, preferably 1.5 h.
4. The use according to claim 2, characterized in that: In the step S2, the concentration method includes vacuum decompression concentration; Preferably, the temperature of the vacuum decompression concentration is 40-90° C.; and / or The vacuum degree of the vacuum decompression concentration is 0.04-0.1MPa; and / or The relative density of the extract at 60° C. is 1.25-1.
30.
5. The use according to claim 2, characterized in that: In step S3, the drying method is vacuum drying, preferably vacuum belt drying; and / or The drying temperature is 105-120°C; and / or The vacuum degree of the drying is 0.04-0.1 MPa, preferably 0.04-0.08 MPa.
6. The use according to claim 2, characterized in that: The Angelica keiskei leaf water extract contains 7.5-17.5 mg / g of total flavonoids.
7. The use according to claim 1, characterized in that: The extract yield of the Angelica keiskei water extract is above 20%, preferably 25%-40%.
8. The use according to claim 7, characterized in that: The product is a food or a medicine.
9. The use according to claim 8, characterized in that: The food is selected from common food or health food.
10. The use according to claim 8, characterized in that: The product is a composition containing Angelica keiskei water extract, grape seed extract and tomato red microcapsules, and / or The dosage form of the product is selected from capsules, powders, granules, tablets or suspensions.
11. The use according to claim 10, characterized in that: The preparation method of the composition containing Angelica keiskei water extract, grape seed extract and lycopene microcapsules comprises: a. The water extract of tomorrow leaf powder, grape seed extract and corn starch, placed together in a mixer, adjusting the speed to 6-15rpm, for example 8rpm, mixing for example 20min, to obtain a mixed powder; b. The mixed powder obtained in step a is dry granulated, the main pressure is set to 6 to 10Mpa, through a 14-mesh sieve, the particles are collected and set aside; c. The particles obtained in step b and the tomato red microcapsules and magnesium stearate are placed in a mixer at a speed of 6-15 rpm, for example 8 rpm, and mixed for example 30 min to obtain a total mixed particle for later use; d. Filling capsules with the total mixed granules prepared in step c.
